CBD shows potential for managing epilepsy, psychosis, anxiety, pain, and inflammation, with emerging evidence for effects on sleep, motor control, and cognition, but products remain largely unregulated and quality and safety standards are lacking.
CBD consumers, neurologists, psychiatrists, regulatory officials, health researchers.
CBD products remain largely unregulated despite widespread therapeutic claims
What the researchers found
CBD has documented therapeutic effects for epileptic seizures, psychosis, anxiety, neuropathic pain, and inflammation. Emerging evidence suggests effects on sleep, motor control, cognition, and memory. CBD influences brain function through multiple mechanisms beyond the endocannabinoid system. Current products do not meet most food safety authority standards for dietary supplements.
Why it matters
CBD has become one of the most popular wellness products globally, but there is a stark gap between consumer interest and regulatory oversight. This review maps what is actually known versus what is marketed.
The numbers in context
No specific quantitative outcomes. Review covers epilepsy, Alzheimer's, Huntington's, Parkinson's, psychosis, anxiety, depression, substance use disorders, sleep, motor control, and cognition.
How the study worked
Comprehensive narrative review synthesizing evidence on CBD's biomolecular properties, mechanisms of action, effects on neurological and mental disorders, behavioral effects, and regulatory considerations.
What this study cannot tell us
Narrative review without systematic methodology. Many covered topics have limited human evidence. Cannot address all CBD product variations and formulations. Regulatory landscape varies by country.
How to read the evidence
Comprehensive narrative review covering multiple conditions. Evidence quality varies from strong (epilepsy) to preliminary (cognition).
When this study was published
Published in 2023.
The bigger picture
The disconnect between CBD's commercial availability and its regulatory status creates a situation where millions of people use products with unverified quality, inconsistent dosing, and uncertain safety. This review argues for responsible research and regulation.
Questions still open
- Will regulatory frameworks catch up with CBD product proliferation?
- Which of CBD's many proposed mechanisms is most clinically relevant?
Common questions
What conditions does CBD actually help with?
Are CBD products safe?
Read the original research
Cannabidiol and brain function: current knowledge and future perspectives.
Frontiers in pharmacology, 14, 1328885
Citation
Schouten, Moniek; Dalle, Sebastiaan; Mantini, Dante; Koppo, Katrien. (2023). Cannabidiol and brain function: current knowledge and future perspectives.. Frontiers in pharmacology, 14, 1328885. https://doi.org/10.3389/fphar.2023.1328885
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk